Your browser doesn't support javascript.
loading
Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology.
Eekers, Daniëlle B P; Di Perri, Dario; Roelofs, Erik; Postma, Alida; Dijkstra, Jeanette; Ajithkumar, Thankamma; Alapetite, Claire; Blomstrand, Malin; Burnet, Neil G; Calugaru, Valentin; Compter, Inge; Coremans, Ida E M; Harrabi, Semi; Iannalfi, Alberto; Klaver, Yvonne L B; Lambrecht, Maarten; Romero, Alejandra Méndez; Paulsen, Frank; Timmermann, Beate; Vitek, Pavel; van der Weide, Hiske L; Whitfield, Gillian A; Nyström, Petra Witt; Zindler, Jaap; de Ruysscher, Dirk; Langendijk, Johannes; Weber, Damien C; Troost, Esther G C.
Afiliación
  • Eekers DBP; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands. Electronic address: danielle.eekers@maastro.nl.
  • Di Perri D; Department of Radiation Oncology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
  • Roelofs E; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands.
  • Postma A; Department of Radiology and Nuclear Medicine MUMC+, Maastricht, The Netherlands.
  • Dijkstra J; Department of Medical Psychology MUMC+, Maastricht, The Netherlands.
  • Ajithkumar T; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, United Kingdom.
  • Alapetite C; Institut Curie, Radiation Oncology Department, Paris & Proton Center, Orsay, France.
  • Blomstrand M; Department of Oncology, Sahlgrenska University Hospital Gothenburg, Sweden.
  • Burnet NG; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Calugaru V; Institute Curie, Paris, France; Institute Curie, Centre de Protonthérapie d'Orsay, Orsay, France.
  • Compter I; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands.
  • Coremans IEM; Leiden University Medical Centre, Department of Radiotherapy, Leiden, The Netherlands; HollandPTC, Delft, The Netherlands.
  • Harrabi S; Department of Radiotherapy, Heidelberg, Germany.
  • Iannalfi A; Clinical Department, Radiotherapy Unit, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Klaver YLB; Leiden University Medical Centre, Department of Radiotherapy, Leiden, The Netherlands; HollandPTC, Delft, The Netherlands; Department of Radiotherapy, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Lambrecht M; Department of Radiotherapy-Oncology, Leuven Kanker Instituut, UZ Gasthuisberg, Belgium.
  • Romero AM; HollandPTC, Delft, The Netherlands; Department of Radiotherapy, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Paulsen F; Department of Radiation Oncology, Eberhard-Karls-Universität Tübingen, Germany.
  • Timmermann B; Clinic for Particle Therapy, University Hospital Essen, West German Cancer Center (WTZ), Germany; West German Proton Therapy Center Essen (WPE), Germany; German Cancer Consortium (DKTK), partnersite Essen, Essen, Germany.
  • Vitek P; Proton Therapy Center Czech, Prague, Czech Republic.
  • van der Weide HL; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Whitfield GA; The University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, United Kingdom; The Children's Brain Tumour Research Network, University of Manchester, Royal Manchester Children's Hospital, United Kingdom.
  • Nyström PW; Danish Centre for Particle Therapy, Aarhus, Denmark.
  • Zindler J; HollandPTC, Delft, The Netherlands; Haaglanden Medisch Centrum, Department of Radiotherapy, Leidschendam, The Netherlands.
  • de Ruysscher D; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands.
  • Langendijk J; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Weber DC; Paul Scherrer Institut, Center for Proton Therapy, Villigen-PSI, Switzerland.
  • Troost EGC; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany; OncoRay - National Center for Radiation Re
Radiother Oncol ; 160: 259-265, 2021 07.
Article en En | MEDLINE | ID: mdl-34015385
ABSTRACT
BACKGROUND AND

PURPOSE:

To update the digital online atlas for organs at risk (OARs) delineation in neuro-oncology based on high-quality computed tomography (CT) and magnetic resonance (MR) imaging with new OARs. MATERIALS AND

METHODS:

In this planned update of the neurological contouring atlas published in 2018, ten new clinically relevant OARs were included, after thorough discussion between experienced neuro-radiation oncologists (RTOs) representing 30 European radiotherapy-oncology institutes. Inclusion was based on daily practice and research requirements. Consensus was reached for the delineation after critical review. Contouring was performed on registered CT with intravenous (IV) contrast (soft tissue & bone window setting) and 3 Tesla (T) MRI (T1 with gadolinium & T2 FLAIR) images of one patient (1 mm slices). For illustration purposes, delineation on a 7 T MRI without IV contrast from a healthy volunteer was added. OARs were delineated by three experienced RTOs and a neuroradiologist based on the relevant literature.

RESULTS:

The presented update of the neurological contouring atlas was reviewed and approved by 28 experts in the field. The atlas is available online and includes in total 25 OARs relevant to neuro-oncology, contoured on CT and MRI T1 and FLAIR (3 T & 7 T). Three-dimensional (3D) rendered films are also available online.

CONCLUSION:

In order to further decrease inter- and intra-observer OAR delineation variability in the field of neuro-oncology, we propose the use of this contouring atlas in photon and particle therapy, in clinical practice and in the research setting. The updated atlas is freely available on www.cancerdata.org.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Planificación de la Radioterapia Asistida por Computador / Oncología por Radiación Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Planificación de la Radioterapia Asistida por Computador / Oncología por Radiación Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2021 Tipo del documento: Article
...